Matthias L Schroeter Selected Research

Dystonia (Limb Dystonia)

11/2018

Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias L Schroeter Research Topics

Disease

16	Dementia (Dementias) 01/2022 - 01/2010
16	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
13	Atrophy 01/2017 - 07/2007
10	Cognitive Dysfunction 01/2021 - 01/2012
9	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2013
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2021 - 06/2010
8	Schizophrenia (Dementia Praecox) 01/2016 - 08/2003
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2011
5	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 01/2011
5	Mood Disorders (Mood Disorder) 03/2015 - 12/2008
3	Hypertension (High Blood Pressure) 01/2020 - 04/2016
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2018
3	Obesity 01/2019 - 01/2018
2	Tauopathies 01/2022 - 11/2021
2	Corticobasal Degeneration 01/2020 - 01/2017
2	Disease Progression 01/2019 - 01/2018
2	Abdominal Obesity 01/2019 - 01/2018
2	Neurobehavioral Manifestations 05/2018 - 08/2015
2	Prodromal Symptoms 05/2018 - 01/2012
2	Primary Progressive Aphasia 01/2018 - 10/2016
2	Heart Arrest (Cardiac Arrest) 12/2017 - 09/2015
2	Major Depressive Disorder (Major Depressive Disorders) 03/2015 - 12/2008
1	Catatonia 10/2021
1	COVID-19 10/2021
1	Confusion (Bewilderment) 10/2021
1	Hallucinations (Hallucination) 10/2021
1	Autoimmune Diseases of the Nervous System 10/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020
1	Heart Failure 01/2020
1	Inflammation (Inflammations) 01/2019
1	Dystonia (Limb Dystonia) 11/2018
1	Myocardial Infarction 01/2018
1	Stroke (Strokes) 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Overweight 01/2018
1	Ischemia 12/2017
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 10/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2015
1	Vascular Diseases (Vascular Disease) 07/2015
1	Sleep Wake Disorders 07/2015
1	Hypersensitivity (Allergy) 07/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2015
1	Thyroiditis 04/2014
1	Hypothyroidism 04/2014
1	Mental Disorders (Mental Disorder) 01/2012
1	Wernicke Aphasia (Receptive Aphasia) 01/2011

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2007
15	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 07/2007
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2015
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2008
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2013 - 01/2010
4	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 07/2013
4	Phosphopyruvate Hydratase (Enolase)IBA 09/2015 - 12/2008
3	Indicators and Reagents (Reagents)IBA 01/2021 - 08/2015
3	Apolipoproteins E (ApoE)IBA 01/2020 - 05/2015
3	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2018 - 08/2016
2	Amyloid beta-PeptidesIBA 01/2022 - 08/2015
2	Retinaldehyde (Retinal)IBA 01/2021 - 07/2015
2	C-Reactive ProteinIBA 01/2019 - 12/2007
2	Antipsychotic Agents (Antipsychotics)IBA 05/2009 - 08/2003
1	PrionsIBA 01/2022
1	ponceau 4R (E 124)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	AntibodiesIBA 10/2021
1	AutoantibodiesIBA 10/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021
1	IronIBA 10/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2020
1	CytokinesIBA 01/2019
1	Citalopram FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	PlasticsIBA 11/2018
1	Therapeutic UsesIBA 01/2018
1	chitotriosidaseIBA 01/2018
1	DipeptidesIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 10/2016
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 08/2016
1	ApolipoproteinsIBA 04/2016
1	Genetic Markers (Genetic Marker)IBA 07/2015
1	SynucleinsIBA 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2015
1	ProteomeIBA 06/2014
1	Blood Proteins (Serum Proteins)IBA 10/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2012
1	mesoglycanIBA 11/2011
1	Nerve Growth Factors (Neurotrophins)IBA 01/2010

Therapy/Procedure

6	Therapeutics 04/2019 - 11/2011
4	Deep Brain Stimulation 01/2020 - 01/2013
1	Immunotherapy 10/2021
1	Transcranial Magnetic Stimulation 11/2018
1	Electrodes (Electrode) 01/2018
1	Resuscitation 12/2017
1	Aftercare (After-Treatment) 03/2015
1	Duration of Therapy 04/2014